Neurological disorders associated with COVID-19 infection: An Italian multi-center cohort study (NEURO-COVID)doi:10.1016/j.jns.2021.117804Simone BerettaViviana CristilloBeatrice VitiCarlo Morotti ColleoniElisa BianchiVincenzo SilaniAlberto PrioriAlessandro Padovani...
An increasing number of patients have been reported to develop a variety of neurological disorders associated with COVID-19 infection [2, 3]. These neurological manifestations are considered to be related to vascular, inflammatory and infective aetiologies, and include both ischaemic and haemorrhagic ...
Middle East Respiratory Coronavirus Syndrome (MERS), and COVID-19 (coronavirus disese-19), has become a global problem. In addition to causing cardiovascular and respiratory lethal dysfunction, these viruses can cause neurodegeneration leading to neurological disorders. Review ...
but neurological complications have been recognised since early in the pandemic. The major pathophysiological processes leading to neurological damage in COVID-19 are cerebrovascular disease, immunologically mediated neurological disorders and the detrimental effects of critical illness on the nervous system. ...
Covid-19 infection or any virus can temporarily worsen symptoms of Parkinsonism and this will require close attention followed by treatment as well. Patients with chronic immune-mediated neurological conditions such as multiple sclerosis, myasthenia and other disorders, especially those on immunosuppressive...
Neurological diseases are caused by structural, neurochemical, and electrophysiological changes in the brain, spinal cord, and nerves leading to neuronal injury and death. The symptoms of neurological disorders include paralysis, muscle weakness, poor coordination, seizures, loss of sensation, confusion, ...
apprehension and sleep disorders caused by the COVID-19 pandemic may be an additional trigger for epilepsy.90Four SARS-CoV-2-infected patients aged 60–70 years presented with seizures and exhibited elevated blood pressure and renal injury, systemic inflammation, and hypercoagulopathy and were diagnos...
Background: COVID-19 is the disease caused by SARS-COV-2 or novel coronavirus. It is extremely contagious and has capability to produce severe clinical out... S Prakash - 《Journal of Pharmaceutical Research International》 被引量: 0发表: 2021年 Spectrum of Neurologic & Neuroimaging manifestatio...
COVID-19 and neuromuscular system A subset of patients with COVID-19 present with neuromuscular disorders including weakness, sensory loss, and acute neuropathy or Guillain-Barre syndrome (Alberti et al. 2020; Sedaghat and Karimi 2020; Toscano et al. 2020). It is conceivable that the observed ...
[71]. A study, conducted on 165 patients 6 months after their hospitalisation due to COVID-19 revealed that 31.5% of the patients had sleep disorders as one of the common neuropsychiatric symptoms [72]. Poor sleep quality was seen in 34.5% of 1142 COVID-19 patients who were evaluated ...